Search
for

    Sort by

    Research 691–720 of 1000+

    1. Response of alopecia areata of the beard to oral tofacitinib Journal of the American Academy of Dermatology · 2019 · 11 citations
    2. Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata Journal of the American Academy of Dermatology · 2018 · 11 citations
    3. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata Dermatologic Therapy · 2019 · 9 citations
    4. Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib Journal of Dermatological Treatment · 2018 · 9 citations
    5. Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard Curēus · 2020 · 5 citations
    6. TREMendous Macrophages Inhibit Hair Growth Cell Stem Cell · 2019 · 4 citations
    7. Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis Frontiers in Pharmacology · 2025 · 3 citations
    8. Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis Dermatology and Therapy · 2024 · 3 citations
    9. Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women Reproductive Sciences · 2018 · 3 citations
    10. Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe Dermatology and Therapy · 2024 · 2 citations
    11. Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy Journal of Cosmetic Dermatology · 2020 · 2 citations
    12. 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins Journal of Investigative Dermatology · 2018 · 2 citations
    13. Current and future pharmacotherapy for alopecia areata Expert opinion on orphan drugs · 2015 · 2 citations
    14. Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report Cureus · 2025 · 1 citations
    15. Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review Clinical Cosmetic and Investigational Dermatology · 2025 · 1 citations
    16. Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study SKIN The Journal of Cutaneous Medicine · 2025 · 1 citations
    17. Mechanism of PPARα agonist in alopecia areata American Journal of Translational Research · 2025 · 1 citations
    18. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion IP Indian Journal of Clinical and Experimental Dermatology · 2024 · 1 citations
    19. Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies Dermatology and Therapy · 2024 · 1 citations
    20. Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis Journal of Cosmetic Dermatology · 2020 · 1 citations
    21. Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl International Journal of Dermatology · 2019 · 1 citations
    22. Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications Journal of Skin and Sexually Transmitted Diseases · 2026
    23. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    24. Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells Scientific Reports · 2026
    25. Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA Dermatology and Therapy · 2026
    26. Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era Frontiers in Medicine · 2026
    27. Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    28. Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib Dermatology and Therapy · 2026
    29. Pharmacotherapy of alopecia areata Forum Dermatologicum · 2026
    30. Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia Cureus · 2026